SIRT1 和 SIRT2:神经退行性变中的新兴靶点。
SIRT1 and SIRT2: emerging targets in neurodegeneration.
机构信息
Department of Neuroscience, Tufts University School of Medicine, Boston, MA, USA.
出版信息
EMBO Mol Med. 2013 Mar;5(3):344-52. doi: 10.1002/emmm.201302451. Epub 2013 Feb 18.
Sirtuins are NAD-dependent protein deacetylases known to have protective effects against age-related diseases such as cancer, diabetes, cardiovascular and neurodegenerative diseases. In mammals, there are seven sirtuins (SIRT1-7), which display diversity in subcellular localization and function. While SIRT1 has been extensively investigated due to its initial connection with lifespan extension and involvement in calorie restriction, important biological and therapeutic roles of other sirtuins have only recently been recognized. Here, we review the potential roles and effects of SIRT1 and SIRT2 in neurodegenerative diseases. We discuss different functions and targets of SIRT1 and SIRT2 in a variety of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's Disease (HD). We also cover the role of SIRT1 in neuronal differentiation due to the possible implications in neurodegenerative conditions, and conclude with an outlook on the potential therapeutic value of SIRT1 and SIRT2 in these disorders.
沉默调节蛋白是一种依赖 NAD 的蛋白去乙酰化酶,已知对与年龄相关的疾病(如癌症、糖尿病、心血管疾病和神经退行性疾病)具有保护作用。在哺乳动物中,有七种沉默调节蛋白(SIRT1-7),它们在亚细胞定位和功能上表现出多样性。虽然 SIRT1 因其最初与寿命延长的联系以及与热量限制的参与而被广泛研究,但其他沉默调节蛋白的重要生物学和治疗作用直到最近才被认识到。在这里,我们综述了 SIRT1 和 SIRT2 在神经退行性疾病中的潜在作用和影响。我们讨论了 SIRT1 和 SIRT2 在各种神经退行性疾病中的不同功能和靶点,包括阿尔茨海默病(AD)、帕金森病(PD)和亨廷顿病(HD)。我们还涵盖了 SIRT1 在神经元分化中的作用,因为这可能对神经退行性疾病有影响,并对 SIRT1 和 SIRT2 在这些疾病中的潜在治疗价值进行了展望。